## References

1. Charles L, Triscott J, Dobbs B. Secondary hypertension: discovering the underlying cause. Am Fam Physician 2017;96: 453-61.  
2. Rimoldi SF, Scherrer U, Messerli FH. Secondary arterial hypertension: when, who, and how to screen? Eur Heart J 2014; 35:1245-54.  
3. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018; 71(19):e127-e248.  
4. Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2016;101:1889-916.  
5. Stowasser M, Sharman J, Leano R, et al. Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocrinol Metab 2005;90:5070-6.  
6. Vilela LAP, Almeida MQ. Diagnosis and management of primary aldosteronism. Arch Endocrinol Metab 2017;61:30512.  
7. Funder JW. Aldosterone and mineralocorticoid receptors - physiology and pathophysiology. Int J Mol Sci 2017;18(5): E1032.  
8. Sharma ST, Nieman LK. Cushing's syndrome: all variants, detection, and treatment. Endocrinol Metab Clin North Am 2011;40:379-91.  
9. Sharma ST. An individualized approach to the evaluation of Cushing syndrome. Endocr Pract 2017;23:726-37.  
10. Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing's syndrome. Lancet 2015;386:913-27.  
11. Masri-Iraqi H, Robenshtok E, Tzvetov G, Manistersky Y, Shimon I. Elevated white blood cell counts in Cushing's disease: association with hypercortisolism. Pituitary 2014;17:436-40.  
12. Stuijver DJ, van Zaane B, Feelders RA, et al. Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study. J Clin Endocrinol Metab 2011;96:3525-32.  
13. Kamenický P, Redheuil A, Roux C, et al. Cardiac structure and function in Cushing's syndrome: a cardiac magnetic resonance imaging study. J Clin Endocrinol Metab 2014;99(11):E2144-E2153.  
14. Toja PM, Branzi G, Ciambellotti F, et al. Clinical relevance of cardiac structure and function abnormalities in patients with Cushing's syndrome before and after cure. Clin Endocrinol (Oxf) 2012;76: 332-8.  
15. Burger HG. Androgen production in women. Fertil Steril 2002;77:Suppl 4:S3-S5.  
16. Lacroix A, Hamet P, Boutin J-M. Leuprolide acetate therapy in luteinizing hormone–dependent Cushing's syndrome. N Engl J Med 1999;341:1577-81.  
17. Salgado LR, Fragoso MC, Knoepfelmacher M, et al. Ectopic ACTH syndrome: our experience with 25 cases. Eur J Endocrinol 2006;155:725-33.  
18. Sathyakumar S, Paul TV, Asha HS, et al. Ectopic Cushing syndrome: a 10-year experience from a tertiary care center in southern India. Endocr Pract 2017;23:907-14.  
19. Alexandraki KI, Grossman AB. The ectopic ACTH syndrome. Rev Endocr Metab Disord 2010;11:117-26.  
20. Torpy DJ, Mullen N, Ilias I, Nieman LK. Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases. Ann N Y Acad Sci 2002;970:134-44.  
21. Valassi E, Crespo I, Keevil BG, et al. Affective alterations in patients with Cushing's syndrome in remission are associated with decreased BDNF and cortisone levels. Eur J Endocrinol 2017;176: 221-31.  
22. Morton A. Ectopic adrenocorticotropin syndrome. Intern Med J 2017;47:1328-9.

Copyright © 2018 Massachusetts Medical Society.